This study suggests that childhood exposure to a toxin produced by certain strains of E. coli may play a role in the rising incidence of colorectal cancer in people aged under 50. Conducted by researchers from the University of California, San Diego, the paper found that genetic mutations linked to a bacterial toxin called colibactin were far more prevalent in tumors from younger patients. These mutations, potentially caused by early-life exposure to colibactin, may disrupt DNA in colon cells and increase cancer risk later in life.
The researchers analyzed DNA from 981 colorectal tumors across 11 countries and discovered that hallmark mutations from colibactin were over three times as common in patients under the age of 40 compared to those aged over 70. These specific mutations were also more frequent in countries with the highest rates of early-onset colorectal cancer. While the presence of these mutations doesn’t prove that colibactin causes cancer, the findings raise concerns about how children become exposed to the toxin, particularly since about 30 to 40 percent of children in the United States and the UK carry colibactin-producing E. coli in their gut.
To learn how an optimum intake of vitamin D could potentially slash the risk of developing colon cancer by up to 58 percent, see this article on our website.
Vitamin D May Slash Risk of Colon Cancer by Almost 60 Percent
April 25, 2025Antioxidants May Lower Risk of Endometriosis
May 2, 2025Childhood Toxin Exposure ‘May be Factor in Bowel Cancer Rise in Under-50s’
News
Childhood exposure to a toxin produced by bacteria in the bowel may be contributing to the rise of colorectal cancer in under-50s around the world, researchers say.
[Source: theguardian.com]
[Image source: Adobe Stock]
Comment
This study suggests that childhood exposure to a toxin produced by certain strains of E. coli may play a role in the rising incidence of colorectal cancer in people aged under 50. Conducted by researchers from the University of California, San Diego, the paper found that genetic mutations linked to a bacterial toxin called colibactin were far more prevalent in tumors from younger patients. These mutations, potentially caused by early-life exposure to colibactin, may disrupt DNA in colon cells and increase cancer risk later in life.
The researchers analyzed DNA from 981 colorectal tumors across 11 countries and discovered that hallmark mutations from colibactin were over three times as common in patients under the age of 40 compared to those aged over 70. These specific mutations were also more frequent in countries with the highest rates of early-onset colorectal cancer. While the presence of these mutations doesn’t prove that colibactin causes cancer, the findings raise concerns about how children become exposed to the toxin, particularly since about 30 to 40 percent of children in the United States and the UK carry colibactin-producing E. coli in their gut.
To learn how an optimum intake of vitamin D could potentially slash the risk of developing colon cancer by up to 58 percent, see this article on our website.
Dr. Rath Health Foundation
Related posts
The Grand Canyon’s Water is Supposed to be Pristine. Scientists Just Found Pharmaceuticals in It
Read more